News | April 20, 2026
Pharma stocks face Q4 reality check amid global headwinds
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
India in the Changing Landscape of Life-Sciences Research & Development
His professional background also includes key experience at Matrix Labs and Sun Pharma
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Subscribe To Our Newsletter & Stay Updated
